Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration

Authors not listed

Streetlab · 2026

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries and affects tens of millions of people worldwide, with a rapidly increasing prevalence. It causes irreversible central vision loss and significant difficulties in daily activities, impairing patients' quality of life and independence. Conventional clinical assessments, which focus on visual acuity and retinal imaging, do not fully reflect the functional impact of the disease. Virtual reality (VR) makes it possible to create immersive, controlled environments to accurately measure functional vision and simulate real-life situations. The study proposes to develop a standardized and reproducible functional test in virtual reality that can complement conventional examinations and support clinical and industrial research.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2026). Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration. <em>Streetlab</em>. https://clinicaltrials.gov/study/NCT07433088
Vancouver
Anonymous. Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration. Streetlab. 2026.
BibTeX
@misc{anon2026Valida, title = {Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration}, author = {Anonymous}, journal = {Streetlab}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings